Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

How We Think about Targeting RNA with Small Molecules
Matthew G. Costales, Jessica L. Childs‐Disney, Hafeez S. Haniff, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 17, pp. 8880-8900
Open Access | Times Cited: 133

Showing 1-25 of 133 citing articles:

Targeting RNA structures with small molecules
Jessica L. Childs‐Disney, Xueyi Yang, Quentin M. R. Gibaut, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 10, pp. 736-762
Open Access | Times Cited: 321
RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges
Ai‐Ming Yu, Young Hee Choi, Mei‐Juan Tu
Pharmacological Reviews (2020) Vol. 72, Iss. 4, pp. 862-898
Open Access | Times Cited: 287
RNA splicing dysregulation and the hallmarks of cancer
Robert K. Bradley, Olga Anczuków
Nature reviews. Cancer (2023) Vol. 23, Iss. 3, pp. 135-155
Open Access | Times Cited: 220
PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics
Sajid Khan, Yonghan He, Xuan Zhang, et al.
Oncogene (2020) Vol. 39, Iss. 26, pp. 4909-4924
Open Access | Times Cited: 187
Targeting RNA with small molecules: from fundamental principles towards the clinic
James P. Falese, Anita Donlic, Amanda E. Hargrove
Chemical Society Reviews (2021) Vol. 50, Iss. 4, pp. 2224-2243
Open Access | Times Cited: 161
Small molecule recognition of disease-relevant RNA structures
Samantha M. Meyer, Christopher C. Williams, Yoshihiro Akahori, et al.
Chemical Society Reviews (2020) Vol. 49, Iss. 19, pp. 7167-7199
Open Access | Times Cited: 136
What blocks more anticancer platinum complexes from experiment to clinic: Major problems and potential strategies from drug design perspectives
Kun Peng, Bing‐Bing Liang, Wenting Liu, et al.
Coordination Chemistry Reviews (2021) Vol. 449, pp. 214210-214210
Closed Access | Times Cited: 110
Small molecules and their impact in drug discovery: A perspective on the occasion of the 125th anniversary of the Bayer Chemical Research Laboratory
Hartmut Beck, Michael Härter, B. Hass, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 6, pp. 1560-1574
Open Access | Times Cited: 96
Organometallic anti-tumor agents: targeting from biomolecules to dynamic bioprocesses
Kun Peng, Yue Zheng, Wei Xia, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 8, pp. 2790-2832
Closed Access | Times Cited: 76
The state of the art of PROTAC technologies for drug discovery
Chao Wang, Cangxin Zheng, Han Wang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 235, pp. 114290-114290
Closed Access | Times Cited: 75
Designing strategies of small-molecule compounds for modulating non-coding RNAs in cancer therapy
Rongyan Zhao, Jia Fu, Lingjuan Zhu, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 72
Programming inactive RNA-binding small molecules into bioactive degraders
Yuquan Tong, Yeongju Lee, Xiaohui Liu, et al.
Nature (2023) Vol. 618, Iss. 7963, pp. 169-179
Open Access | Times Cited: 68
Amplifying gene expression with RNA-targeted therapeutics
Olga Khorkova, Jack Stahl, Aswathy Joji, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 7, pp. 539-561
Open Access | Times Cited: 63
Targeting and engineering long non-coding RNAs for cancer therapy
Michela Coan, Simon Haefliger, Samir Ounzain, et al.
Nature Reviews Genetics (2024) Vol. 25, Iss. 8, pp. 578-595
Closed Access | Times Cited: 40
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
Yonghan He, Sajid Khan, Zhiguang Huo, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 87
De novo3D models of SARS-CoV-2 RNA elements from consensus experimental secondary structures
Ramya Rangan, Andrew M. Watkins, Jose Chacon, et al.
Nucleic Acids Research (2021) Vol. 49, Iss. 6, pp. 3092-3108
Open Access | Times Cited: 76
miRNAs and lncRNAs as Novel Therapeutic Targets to Improve Cancer Immunotherapy
Maria Teresa Di Martino, Caterina Riillo, Francesca Scionti, et al.
Cancers (2021) Vol. 13, Iss. 7, pp. 1587-1587
Open Access | Times Cited: 70
Risdiplam, the First Approved Small Molecule Splicing Modifier Drug as a Blueprint for Future Transformative Medicines
Hasane Ratni, R. Scalco, Alexander Stephan
ACS Medicinal Chemistry Letters (2021) Vol. 12, Iss. 6, pp. 874-877
Open Access | Times Cited: 66
Deliver the promise: RNAs as a new class of molecular entities for therapy and vaccination
Ai‐Ming Yu, Mei‐Juan Tu
Pharmacology & Therapeutics (2021) Vol. 230, pp. 107967-107967
Open Access | Times Cited: 64
Progress and Challenges in Targeted Protein Degradation for Neurodegenerative Disease Therapy
Yingxu Fang, Jiaxing Wang, Min Zhao, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 17, pp. 11454-11477
Closed Access | Times Cited: 44
Alkaline Phosphatase-Controllable and Red Light-Activated RNA Modification Approach for Precise Tumor Suppression
Jing Fang, Yali Feng, Yuqi Zhang, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 50, pp. 23061-23072
Closed Access | Times Cited: 35
Contemporary Progress and Opportunities in RNA-Targeted Drug Discovery
Amanda L. Garner
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 3, pp. 251-259
Open Access | Times Cited: 24
Specificity, synergy, and mechanisms of splice-modifying drugs
Yuma Ishigami, Mandy S. Wong, Carlos Martí‐Gómez, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
RNA–Small-Molecule Interaction: Challenging the “Undruggable” Tag
Jaskirat Kaur, Akanksha Sharma, Poonam Mundlia, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 6, pp. 4259-4297
Closed Access | Times Cited: 6
Novel Quinazoline Derivatives Inhibit Splicing of Fungal Group II Introns
Olga Fedorova, M.‐Z. LUO, G. Erik Jagdmann, et al.
ACS Chemical Biology (2025)
Closed Access
Page 1 - Next Page

Scroll to top